OCM
TMO icon

Oribel Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Oribel Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,400
Closed -$19.6M – 146
2025
Q3 		$19.6M Buy
+40,400
New +$18.8M 0.62% 50
2025
Q1 		– Sell
-47,400
Closed -$24.7M – 141
2024
Q4 		$24.7M Buy
+47,400
New +$26.1M 0.84% 46
2023
Q1 		– Sell
-25,200
Closed -$13.9M – 114
2022
Q4 		$13.9M Buy
+25,200
New +$13.4M 1.42% 29
2022
Q1 		– Sell
-47,700
Closed -$31.8M – 191
2021
Q4 		$31.8M Buy
+47,700
New +$29.8M 1.19% 27

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Oribel Capital Management's TMO Position: Q4 2025 in Review

Oribel Capital Management sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 40,400 shares — an estimated $19.6M sold.

Oribel Capital Management first reported a position in TMO in Q4 2021 and held it in 8 quarters. The position peaked at $59.6M in Q4 2023. 2,700 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • Oribel Capital Management reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • Oribel Capital Management sold 40,400 Thermo Fisher Scientific shares in Q4 2025, an estimated $19.6M.
  • Oribel Capital Management first reported a position in Thermo Fisher Scientific in Q4 2021 and held it in 8 quarters.
  • Oribel Capital Management's Thermo Fisher Scientific position peaked at $59.6M in Q4 2023.
  • 2,700 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on Oribel Capital Management's 13F filing for Q4 2025, filed 13 Feb 2026.